Patient recruitment started and first patient consented in the CDNF Phase I-II clinical study

TreatER Horizon 2020 program website launched

How wearable devices can help people with Parkinson’s communicate better with their doctors

200 years of Parkinson’s disease: still no cure, but EU policy must drive improvements in quality of life

World Parkinson’s Day: #Unite for Parkinsons social media campaign

Herantis Pharma’s clinical study with CDNF in Parkinson’s disease authorized in Sweden

OPDC researchers in new drug trial for Parkinson’s